Science Explorer Back to mapMap
Discussion
Researcher · München Klinik Schwabing · Germany

Martin Füchtenbusch

Martin Füchtenbusch publishes mostly in Endocrinology, Diabetes and Metabolism, Genetics and Surgery, on topics such as Diabetes Management and Research, Diabetes and associated disorders and Diabetes Treatment and Management.

OpenAlex
World rank
#3,909,599
of 7,710,434 ranked researchers
Rank in Germany
#196,427
of 364,343
Works
118
Citations
1.6k
Citations per work
13.7
h-index
19
i10-index 27Top 24% in Endocrinology, Diabetes and Metabolism
Martin Füchtenbusch

What does Martin Füchtenbusch research?

Martin Füchtenbusch's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (19%).

Health Sciences: 70 works · 59.3% of their workMedicine: 70 works · 59.3% of their workEndocrinology, Diabetes and Metabolism: 43 works · 36.4% of their workSurgery: 14 works · 11.6% of their workObstetrics and Gynecology: 9 works · 7.3% of their workEpidemiology: 5 works · 4.0% of their workEverything else: 25 works · 21.4% of their workLife Sciences: 23 works · 19.3% of their workBiochemistry, Genetics and Molecular Biology: 23 works · 19.3% of their workGenetics: 19 works · 16.5% of their workMolecular Biology: 3 works · 2.8% of their workTHEIR WORKMartinFüchtenbusch118works
Life Sciences19%Health Sciences59%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7059.3%
  2. Everything else2521.4%
    1. Biochemistry, Genetics and Molecular Biology2319.3%
  1. 1Endocrinology, Diabetes and Metabolism36% of their works
  2. 2Genetics16% of their works
  3. 3Surgery12% of their works
  4. 4Obstetrics and Gynecology7% of their works
  5. 5Epidemiology4% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Martin Füchtenbusch's research?

The keywords of their largest research topics: Type 1 Diabetes, Glycemic Control, Insulin Therapy, Type 2 Diabetes, Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Autoimmunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Type 1 Diabetes1082 topics
  2. Glycemic Control1033 topics
  3. Insulin Therapy1033 topics
  4. Type 2 Diabetes673 topics
  5. Diabetes652 topics
  6. Continuous Glucose Monitoring551 topic
  7. Hypoglycemia551 topic
  8. Autoimmunity531 topic
  9. Genetics531 topic
  10. Cardiovascular Outcomes381 topic
  11. Glucose Control381 topic
  12. Diabetes Mellitus352 topics
  13. Hyperglycemia292 topics
  14. Pancreatic Islets251 topic
  15. ß-Cell Dysfunction251 topic
  16. Gestational Diabetes Mellitus191 topic
  17. Maternal Obesity191 topic
  18. Bariatric Surgery101 topic
  19. Critical Care101 topic
  20. Infection Risk101 topic
  21. Obesity101 topic
  22. AMP-Activated Protein Kinase91 topic
  23. Metformin91 topic

Where does Martin Füchtenbusch work?

Martin Füchtenbusch's main affiliation in the publication record is München Klinik Schwabing, Germany.

How many publications and citations does Martin Füchtenbusch have?

OpenAlex counts 118 works and 1,616 citations for Martin Füchtenbusch, an h-index of 19, ranking #3,909,599 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Martin Füchtenbusch. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.